Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000154006 | SCV000203633 | benign | not specified | 2014-04-25 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000270481 | SCV000372640 | benign | Meckel-Gruber syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000325554 | SCV000372641 | benign | Familial aplasia of the vermis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588729 | SCV000697777 | benign | not provided | 2016-05-02 | criteria provided, single submitter | clinical testing | Variant summary: The c.432-11_432-10insA variant results in insertion of a nucleotide at an intronic location that is not widely known to affect splicing. Mutation taster predicts polymorphism outcome for this variant. 4/5 splice-tools in Alamut predict that this variant does not affect normal splicing. ESE finder predicts that this variant may affect ESE site of SRp40. This variant is found in 100404/116840 control chromosomes (43189 homozygotes) at a frequency of 0.859329, which significantly exceeds the maximal expected frequency of a pathogenic allele (0.0038528), suggesting this variant is a benign polymorphism. In addition, one clinical laboratory classified this variant as benign. Taken together, this variant was classified as benign. |
Gene |
RCV000588729 | SCV000730167 | benign | not provided | 2019-11-19 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988564 | SCV001138330 | benign | Joubert syndrome 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000325554 | SCV001721626 | benign | Familial aplasia of the vermis | 2022-10-07 | criteria provided, single submitter | clinical testing |